Endo International plc
ENDPDelisted Sep 14, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593034
Endo International plc was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Aug 17, 2022; 152 institutions reported holding it in 13F filings for Q2 2022, worth $65.0M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Endo International plc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ENDP is no longer listed, and 13F filings after Q2 2022 list far fewer holders. See Q2 2022
- Institutional holders
- 0
- −1 vs. Q4 2023
- Shares held
- 0
- −10.0K (−100.0%) vs. Q4 2023
- Total value
- $0
- $0 vs. Q4 2023
- New holders
- 0
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENDP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 2 | $132 |
| Q4 2022 | 2 | $134 |
| Q3 2022 | 12 | $193.0K |
| Q2 2022 | 152 | $65.0M |
| Q1 2022 | 208 | $447.4M |
| Q4 2021 | 203 | $706.9M |
| Q3 2021 | 182 | $564.9M |
| Q2 2021 | 204 | $885.8M |
| Q1 2021 | 190 | $1.41B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Endo International plc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hunter Associates Investment Management LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |